Boundless Bio Statistics

Total Valuation

Boundless Bio has a market cap or net worth of $43.71 million. The enterprise value is -$123.31 million.

Market Cap	43.71M
Enterprise Value	-123.31M

Important Dates

The next estimated earnings date is Thursday, April 3, 2025, before market open.

Earnings Date	Apr 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Boundless Bio has 22.30 million shares outstanding. The number of shares has increased by 881.66% in one year.

Current Share Class	22.30M
Shares Outstanding	22.30M
Shares Change (YoY)	+881.66%
Shares Change (QoQ)	+1.05%
Owned by Insiders (%)	1.75%
Owned by Institutions (%)	52.86%
Float	14.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.26
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.03, with a Debt / Equity ratio of 0.00.

Current Ratio	17.03
Quick Ratio	16.70
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.16% and return on invested capital (ROIC) is -28.55%.

Return on Equity (ROE)	-41.16%
Return on Assets (ROA)	-26.97%
Return on Invested Capital (ROIC)	-28.55%
Return on Capital Employed (ROCE)	-41.67%
Revenue Per Employee	n/a
Profits Per Employee	-$848,042
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.48
200-Day Moving Average	4.08
Relative Strength Index (RSI)	33.64
Average Volume (20 Days)	49,999

Short Selling Information

The latest short interest is 330,942, so 1.48% of the outstanding shares have been sold short.

Short Interest	330,942
Short Previous Month	354,028
Short % of Shares Out	1.48%
Short % of Float	2.33%
Short Ratio (days to cover)	10.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.79M
Pretax Income	n/a
Net Income	-61.06M
EBITDA	-67.75M
EBIT	-68.79M
Earnings Per Share (EPS)	-$5.21

Full Income Statement

Balance Sheet

The company has $167.14 million in cash and $121,000 in debt, giving a net cash position of $167.01 million or $7.49 per share.

Cash & Cash Equivalents	167.14M
Total Debt	121,000
Net Cash	167.01M
Net Cash Per Share	$7.49
Equity (Book Value)	165.08M
Book Value Per Share	7.42
Working Capital	160.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.96 million and capital expenditures -$2.34 million, giving a free cash flow of -$59.30 million.

Operating Cash Flow	-56.96M
Capital Expenditures	-2.34M
Free Cash Flow	-59.30M
FCF Per Share	-$2.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Boundless Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-881.66%
Shareholder Yield	-881.66%
Earnings Yield	-139.71%
FCF Yield	-135.69%

Analyst Forecast

The average price target for Boundless Bio is $22.50, which is 1,047.96% higher than the current price. The consensus rating is "Buy".

Price Target	$22.50
Price Target Difference	1,047.96%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2